Computer Motion Announces the Hiring of Eugene W. Teal as Executive Vice President, Finance & Administration.

Business Editors

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Feb. 12, 2002

Computer Motion, Inc. (Nasdaq:RBOT), the world's leading developer of surgical robotic systems, today announced the hiring of Eugene W. Teal as Executive Vice President, Finance & Administration.

"I am very pleased with the quality of the talent we are attracting now. Our most recent hire is Gene Teal, Computer Motion's Executive Vice President, Finance & Administration. Gene comes to us with an outstanding background. He is a seasoned executive with a thorough understanding of business procedure and process. We expect major contributions from him as we proceed on our pathway to profitability," stated Robert W. Duggan, Chairman and CEO of Computer Motion.

Eugene W. Teal has had extensive international experience as a consultant with McKinsey and Company, Inc. Separately, he has managed over twenty profit centers as a division manager. He joins Computer Motion from a position as Business Consulting Director at Oracle Corporation. Mr. Teal holds an MBA in Finance from UCLA.

Computer Motion is a high-tech medical device company evolving surgical practices to enhance patient lives. The company develops, manufactures and markets proprietary computer-enhanced and robotic surgical systems that enhance surgeons' capabilities, improve patient outcomes and reduce costs. Computer Motion plays a significant role in transitioning the surgical community from current open procedures to endoscopic procedures that are less painful and traumatic to the patient. Computer Motion's FDA-cleared products include: the ZEUS(R) Robotic Surgical System for new minimally invasive microsurgery, the HERMES(TM) Control Center, a centralized system that enables the surgeon to voice control a network of "smart" medical devices, and the AESOP(R) Robotic Endoscope Positioner, which was also the first FDA-cleared surgical robot to be made commercially available in the U.S. The company's newest product, the SOCRATES(TM) Telecollaboration System, is the first device to be cleared by the FDA in the newly created category of Robotic Telemedicine Devices, and is designed to facilitate surgeon collaboration using video and audio conferencing, shared control of the endoscopic camera, and video annotation on the surgical image in the operating room. The company's products are CE-Marked for commercial sale in the European Community. The company's Web site is www.ComputerMotion.com.

This press release contains forward-looking statements concerning the company's business and products. Actual results may differ materially depending on a number of risk factors, including the risks of competition and competing technologies, duration or suspension of clinical studies, regulatory clearances and approvals, and physician, hospital and payor acceptance of the company's products. These factors and other risks inherent in the company's business are described from time to time in the company's Securities and Exchange Commission filings, including its Annual Report on Form 10-K. The company undertakes no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof to reflect the occurrence of unanticipated events.